
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Mirum Pharmaceuticals, Inc
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI (maralixibat) oral solution, CHOLBAM (cholic acid) capsules, and CHENODAL (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients five years of age and older. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms or liver disease. CHENODAL has received medical necessity recognition by the FDA to treat patie...
C-Level 0 | VP - Level- |
Director- | Manager19 |
Others204 |
Structure | Email Format |
---|---|
<f><last>@ |
|
<first>.<last>@ | John.Smith@mirumpharma.com |
Pain Points | Locations | Technologies |
---|---|---|
Account Payable | Boston, MA | communication, exchange, assessment, compliance, e |
Account Payable | Foster City, CA | customer service, firewall, compliance, audit, active directory, directory, scheduling, networking, communication, root cause analysis, mobile, spreadsheet, payroll, windows, collaboration, payment, hoc, database, infrastructure, sox, financial, basic, testing, e, presence, operations |
Account Payable | Zug, Zug, Switzerland | packaging, communication, basic, quality assurance, gmp, assessment, compliance, talent acquisition, e, change control, operations, procedure |
Account Receivable | Foster City, CA | communication, hoc, compliance, audit, financial, payroll, payment, collaboration, operations |
Account Receivable | Zug, Zug, Switzerland | packaging, communication, basic, quality assurance, gmp, assessment, compliance, e, change control, procedure |
Mirum Pharmaceuticals, Inc looking to hire in BI in Brabantine City Row
Mirum Pharmaceuticals, Inc looking to hire in Compliance in Brabantine City Row
Mirum Pharmaceuticals, Inc looking to hire in Database Administration in Brabantine City Row
Fortinet
Gcp
Netsuite
Power automate
Access
Agile
Acceptance testing
Accessibility
Active directory
Analytics
MISSIONMirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatme...
View MoreMISSIONMirum focuses on finding and developing drugs for difficult to treat liver diseases. Our l...
View MoreMISSIONMirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatme...
View MoreMISSIONMirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatme...
View MoreMISSIONMirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatme...
View MoreMISSIONMirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatme...
View MoreMISSIONMirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatme...
View MoreMISSIONMirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatme...
View MoreMirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI (maralixibat) oral solution, CHOLBAM (cholic acid) capsules, and CHENODAL (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients five...
Mirum pharmaceuticals, inc operates in the Pharmaceutical manufacturing industry.
Mirum pharmaceuticals, inc's revenue is 101m - 500m
Mirum pharmaceuticals, inc has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.